In October 2024, Lilly announced a partnership with Health Innovation Manchester and The University of Manchester to initiate a five-year real-world study, SURMOUNT-REAL UK [9]
Li W, Long Q, Wu H, Zhou Y, Duan L, Yuan H, et al
More specifically, retatrutide is often described as a GLP-1/GIP/glucagon receptor agonist
*** Hng dn s dng: - S dng 1 gi mi ngy, c th ngm di li trc tip hoc pha vi nc v cc thc ung khc ty theo s thch - V du chua ngt, d ung - Thi im khuyn dng sau khi n sng - Ung nhiu nc khong 2 lt mi ngy trong sut qu trnh s dng - Lu : i vi nhng bn c d dy nhy cm, nn dng sn phm sau khi n no v c th pha vi nc gip hp th d hn, trnh cm gic kh chu
While anaphylactoid reactions to NAC can be concerning, they are generally mild, transient, and manageable with appropriate interventions, ensuring that patients continue to receive the hepatoprotective benefits of NAC [29]
Treatment selection depends on the specific autoimmune condition and disease severity